March 18th 2024
From our March cover feature: Vulnerable populations such as the prison population should have access to Mohs surgery to prevent the increased risk of morbidity and mortality from skin cancer.
Study: Curcumin Nanoparticles as a Photoprotective Adjuvant
August 24th 2021Curcumin has a long history as an effective treatment for everything from chronic pain to skin infections. Nanoparticle encapsulation shows promise in meeting that challenge and opening the way for a safe, effective adjuvant to sunscreen.
Valisure CEO Shares Thoughts on Johnson & Johnson Sunscreen Recall
August 4th 2021In this video interview, David Light, CEO of Valisure, shares his thoughts on the recent sunscreen recall from Johnson & Johnson due to benzene contamination and reveals how the FDA and sun protection companies can make sure this never happens again.
Physician Provides Update on Benzene Contamination in Sunscreens
July 29th 2021In this exclusive video interview, Christopher Bunick, MD, PhD, gives Dermatology Times an update on benzene contamination being detected in various sunscreens and after-sun care products, as well as a recent recall by Johnson & Johnson.
Physician Weighs in on Sunscreen Contamination Controversy
May 28th 2021Christopher Bunick, MD, PhD, associate professor of dermatology, Yale University and Dermatology Times® editorial advisory board member, weighs in on a recent report revealing certain batches of various sunscreen and after-sun care products were contaminated with benzene, a carcinogen.
Valisure Highlights Controversy of Benzene Contamination in Sunscreen Products
May 26th 2021David Light, founder and CEO of Valisure, the independent lab that discovered the presence of benzene in multiple brands and batches of sunscreen, sits down with Dermatology Times to discuss the reports' findings and the impact this news will have on the sun protection industry.
Study: SGX301 Demonstrates Efficacy for Treatment of Cutaneous T-cell Lymphoma
May 6th 2021New data from a phase 3 study evaluating SGX301 for treatment of cutaneous T-cell lymphoma (CTCL) skin symptoms was recently presented at the American Academy of Dermatology Virtual Meeting Experience (AAD VMX 2021).
Tirbanibulin Compared to 5-Fluorouracil for Treatment of Actinic Keratosis
April 19th 2021Todd Schlesinger, MD, FAAD, outlines his research on newly FDA-approved topical tirbanibulin (Klisyri, Almirall) for treatment of actinic keratosis (AK), as well as compares it to another topical treatment for AK, 5-fluorouracil.